No Result
View All Result
  • Private Data
  • Membership options
  • Login
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHubHOT
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Subscribe
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHubHOT
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Home COUNTRY FRANCE

BariaTek Medical Receives € 1.5M DeepTech Non-dilutive Financing From Bpifrance BariTon™ Device to Enter Clinical Trials to Treat Obesity and Diabetes in the Near Future

Business Wireby Business Wire
September 19, 2023
Reading Time: 3 mins read
in FRANCE, GREEN
Share on FacebookShare on Twitter

Obesity and diabetes are high medical need pandemics

PARIS–(BUSINESS WIRE)–BariaTek Medical, a privately held medical device company dedicated to the development of minimally invasive endoscopically delivered solutions to treat obesity and diabetes, founded by Truffle Capital, announced it has secured a non-dilutive DeepTech financing of € 1.5 million from Bpifrance, under the “France 2030” plan, to accelerate the company’s development towards its imminent human feasibility clinical trials.

Obesity and diabetes are debilitating conditions affecting more than 1 billion patients worldwide; they are the most costly chronic conditions to healthcare systems surpassing cardiovascular diseases and cancer and their prevalence is increasing. Obesity and diabetes are pandemics increasingly affecting patients in every corner of the globe.

Bariatric surgery remains the only sustainable solution to treat obesity and the resulting diabetes, but surgery is invasive, is associated with complexity, complications, and high costs. The new GLP-1 receptor agonists drugs can be effective but very costly, need to be taken long-term, leading to high burden on payors and patient non-compliance.

BariaTek Medical’s first product, the BariTon™, is a soft, atraumatic, reversible implant that is delivered via an endoscope through the mouth in a few minutes in an outpatient setting. The BariTon™ is expected to be the first implant of its kind to mimic the efficacy of bypass surgery and surpass it in terms of safety, ease of use, reversibility, and economics.

Youssef Biadillah, CEO of BariaTek Medical said: “This € 1.5 million non-dilutive financing provided by Bpifrance is a testament to the potential of BariaTek and its lead product candidate BariTon™ to address two galloping pandemics, obesity and diabetes, which affect more than 18% of the French adult population, 42% of the US population and a billion patients worldwide. We look forward to bringing the BariTon™ into clinical trials in the very near term.”

Antoine Pau, Chairman of BariaTek Medical said: “Thanks to its experienced team, BariaTek has managed to develop in a short period of time a highly differentiated solution that could radically change the treatment of obesity and diabetes. BariaTek is now initiating a private fundraising to finance the next steps and make BariTon™ available to patients as soon as possible.”

About BariaTek Medical

BariaTek Medical, based in Paris France, is a privately held medical device company dedicated to the development of minimally invasive endoscopically delivered solutions to treat obesity and diabetes. BariaTek Medical was founded by Truffle Capital, a premier life science VC fund based in Paris France and founder or co-founder of various life science companies such as Abivax (Euronext : ABVX), Carmat (Euronext: ALCAR), Carbios (Euronext ALCRB), Vexim (acquired by Stryker), Symetis (acquired by Boston Scientific) and Affluent Medical (Euronext : AFME).

About Truffle Capital

Truffle Capital is an independent European Venture Capital firm specializing in disruptive technologies in the Life Sciences (Biotech, Medtech, BioEcotech) and IT sectors (Fintech and Insurtech). Truffle Capital’s mission is to support the creation and development of innovative companies capable of becoming the leaders of tomorrow. Chaired by Patrick Kron and managed by Dr. Philippe Pouletty and Bernard-Louis Roques, Co-founders and Managing Directors, Truffle Capital manages €600 million in assets. It has raised more than €1.1 billion since its creation and has supported more than 75 companies in the life sciences and digital technology sectors.

Contacts

armandrigaudy@primatice.com

Read the orginal article: http://www.businesswire.com/news/home/20230919587722/en/BariaTek-Medical-Receives-%E2%82%AC-1.5M-DeepTech-Non-dilutive-Financing-From-Bpifrance-BariTon%E2%84%A2-Device-to-Enter-Clinical-Trials-to-Treat-Obesity-and-Diabetes-in-the-Near-Future/?feedref=Zd8jjkgYuzBwDixoAdXmJgT1albrG1Eq4mAeVP392135TeTcEtB_02B3_LaRI8NDevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxYvSRPwl8-_l9-Y8T4ahCUmuLAuCkn8FS6sh-I3dfDZEg==

Gateways to Italy

Gateways to Italy – Offer your services to funds and investors willing to explore opportunities in Italy. Become a partner!

Gateways to Italy – Offer your services to funds and investors willing to explore opportunities in Italy. Become a partner!

by Partner
June 6, 2023

Sign up to our newsletter

SIGN UP

Related Posts

GREEN

AVK underlines ethical and environmental credentials with appointment of new head of corporate social responsibility

June 9, 2025
GREEN

Government pledges to unleash a ‘rooftop revolution’ with compulsory solar panels

June 9, 2025
GREEN

Prefab data center deployed in Merikarvia, Finland, to power district heating network

June 8, 2025

ItaHub

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

November 4, 2024
Italy’s SMEs export toward 260 bn euros in 2025

Italy’s SMEs export toward 260 bn euros in 2025

September 9, 2024
With two months to go before the NPL Directive, in Italy the securitization rebus is still to be unraveled

With two months to go before the NPL Directive, in Italy the securitization rebus is still to be unraveled

April 23, 2024
EU’s AI Act, like previous rules on technology,  looks more defensive than investment-oriented

EU’s AI Act, like previous rules on technology, looks more defensive than investment-oriented

January 9, 2024

Co-sponsor

Premium

Funds vying for management consulting firm BIP, a CVC portfolio company. All deals in the sector

Funds vying for management consulting firm BIP, a CVC portfolio company. All deals in the sector

March 6, 2025
Private equity, Italy 2024 closes with 588 deals as for investments and divestments from 549 in 2023. Here is the new BeBeez’s report

Private equity, Italy 2024 closes with 588 deals as for investments and divestments from 549 in 2023. Here is the new BeBeez’s report

February 10, 2025
Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

November 4, 2024
Venture capital investments top €1.3bn in 208 rounds as of Sep30  in Italy. They were €1.5 in all 2023. The new BeBeez Report

Venture capital investments top €1.3bn in 208 rounds as of Sep30 in Italy. They were €1.5 in all 2023. The new BeBeez Report

October 28, 2024
Next Post

Allied Industrial Partners-Backed CES Power Acquires Euro Touring Power

Graz-based Metaloop raised €16 million to accelerate their growth & reduce carbon emissions

EdiBeez srl

C.so Italia 22 - 20122 - Milano
C.F. | P.IVA 09375120962
Aut. Trib. Milano n. 102
del 3 aprile 2013

COUNTRY

Italy
Iberia
France
UK&Ireland
Benelux
DACH
Scandinavia&Baltics

CATEGORY

Private Equity
Venture Capital
Private Debt
Distressed Assets
Real Estate
Fintech
Green

PREMIUM

ItaHUB
Legal
Tax
Trend
Report
Insight view

WHO WE ARE

About Us
Media Partnerships
Contact

INFORMATION

Privacy Policy
Terms&Conditions
Cookie Police

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHub
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Subscribe
  • Login
  • Cart